The overall rates of HER3, Akt, p-Akt, mTOR, p-mTOR positive expression in patients with GC were 26.7%, 67.2%, 54.8%, 53.9% and 48.3%, respectively. The gene discussed is MTOR; the disease is gastric cancer.